KK-LC-1/MC-38
CBPG0056
詢 價
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| KK-LC-1一種極具前景的癌癥免疫治療新靶點。 它是一種在正常情況下僅于睪丸中表達的癌-睪丸抗原，而在肺癌、胃癌、肝癌等多種實體瘤中均有特異性高表達，這一特性使其成為了開發(fā)精準免疫療法的理想“路標”。 | |
| II. Introduction | |
| Host Cell: | MC-38 |
| Expressed gene: | KK-LC-1 |
| Stability: | 32 passages |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+2μg/ml Puromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| III. Description of Host Cell Line | |
| Organism: | Mouse |
| Tissue: | Colon |
| Morphology: | Epitheloid cell |
| Growth Properties: | Adherent |
| IV. Representative Data | |
 Figure 1. Recombinant KK-LC-1/MC-38 constitutively expressing KK-LC-1. |
|
| V. In VIVO Data | |
|
Index |
Content |
|
Animal |
C57BL/6J, 7weeks, female |
|
Implanted Position |
Subcutaneous (right flank region) |
|
Injected Cell Numbers |
1×10^6/0.1ml |
|
Matrix gel |
Without matrix gel |
1. Weight Change
Figure 2. KK-LC-1/MC38 Mean Body Weight ± SEM.
2. Tumor Volume
Figure 3. KK-LC-1/MC38 Mean Tumor Volume ± SEM.
NOTE：The above data was provided by Cobioer (cell data) and Truway Bio (in vivo data model).
